Drug intelligence / Profile preview

S-PRP

Development stage: Unknown
Lead developer: MetaTech Biomed
Modality: Cell Therapies
Administration: Injection, Topical

Overview

Super PRP (S-PRP) is an autologous biologic therapy developed by MetaTech Biomed for aesthetic and regenerative dermatological applications. It is a next-generation platelet-rich plasma (PRP) product that contains a significantly higher concentration (5x to 7x) of platelets and growth factors compared to standard PRP preparations. By delivering concentrated autologous growth factors—including platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), vascular endothelial growth factor (VEGF), and epidermal growth factor (EGF)—directly to targeted skin areas, it stimulates cellular regeneration, collagen production, and tissue healing. It is primarily used for skin rejuvenation and general skin care.

Brand names: Super PRP
Other names: 超級PRPMetaTech Super PRP

Beyond the preview

Go deeper on S-PRP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on S-PRP.

Explore the full profile